STERIS plc
215.09USD
-3.3500 (-1.53%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.68▼ | $2.69 | 0 | 2 |
| Next quarter | $2.81▼ | $2.81 | 0 | 4 |
| Current year | $11.17▲ | $11.15 | 5 | 1 |
| Next year | $12.25▲ | $12.1 | 6 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.49 | $2.59 | +0.10 (+3.9%) |
| 2026-03-31 | $2.85 | $2.83 | -0.02 (-0.7%) |
| 2025-12-31 | $2.53 | $2.53 | -0.00 (-0.1%) |
| 2025-09-30 | $2.35 | $2.47 | +0.12 (+5.1%) |
95 ratings from 14 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Buy | $275 $270 | Aug 7, 2026 |
| Piper Sandler | Reiterated | Overweight | $270 $275 | Aug 7, 2026 |
| UBS | Initiated | Buy | $275 | Jul 28, 2026 |
| Keybanc | Maintained | Overweight | $291 $269 | May 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $276 $295 | Aug 8, 2025 |
| Keybanc | Maintained | Overweight | $277 $288 | Jul 22, 2025 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $260 $276 | Jul 15, 2025 |
| Jefferies | Initiated | Hold | $263 | May 29, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $240 $260 | May 19, 2025 |
| JMP Securities | Maintained | Market Outperform | $265 $280 | May 16, 2025 |
| Stephens & Co. | Reiterated | Overweight | $250 | May 15, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $230 $240 | May 12, 2025 |
| JMP Securities | Reiterated | Market Outperform | $265 | Apr 10, 2025 |
| Needham | Reiterated | Hold | — | Apr 7, 2025 |
| JMP Securities | Reiterated | Market Outperform | $265 | Feb 6, 2025 |
| Stephens & Co. | Reiterated | Overweight | $240 | Feb 6, 2025 |
| Piper Sandler | Maintained | Overweight | $260 $265 | Feb 3, 2025 |
| JMP Securities | Reiterated | Market Outperform | $265 | Nov 18, 2024 |
| Needham | Reiterated | Hold | — | Nov 8, 2024 |
| Stephens & Co. | Reiterated | Overweight | $260 | Nov 7, 2024 |
| Piper Sandler | Upgraded from Neutral | Overweight | $230 $260 | Oct 24, 2024 |
| Needham | Reiterated | Hold | — | Aug 8, 2024 |
| JMP Securities | Reiterated | Market Outperform | $265 | Aug 7, 2024 |
| Stephens & Co. | Reiterated | Overweight | $260 | Aug 7, 2024 |
| JMP Securities | Reiterated | Market Outperform | $265 | Jul 26, 2024 |
55 filings from 13 insiders · 12 buy / 4 sell over 6m
Officers and directors of STE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SOHI MOHSEN MDirector | Exercise | 4.1k | $86.23 | $350k | Aug 12, 2026 |
| SOHI MOHSEN MDirector | Sell | 4.1k | $235.78 | $957k | Aug 12, 2026 |
| SOHI MOHSEN MDirector | Exercise | 3.8k | $71.40 | $270k | Jul 1, 2026 |
| ZANGERLE JOHN ADAMGeneral Counsel | Sell | 1.4k | $209.28 | $297k | Jun 15, 2026 |
| CARESTIO DANIEL AChief Executive Officer | Sell | 4.4k | $212.00 | $947k | Jun 5, 2026 |
| CARESTIO DANIEL AChief Executive Officer | Grant | 23.7k | — | — | Jun 2, 2026 |
| BURTON KAREN LChief Financial Officer | Grant | 5.3k | — | — | Jun 2, 2026 |
| TAMARO RENATOOfficer and Treasurer | Grant | 750 | — | — | Jun 2, 2026 |
| MAJORS CARY LOfficer | Grant | 4.7k | — | — | Jun 2, 2026 |
| FRASER MARY CLAREOfficer | Grant | 3.0k | — | — | Jun 2, 2026 |
| MADSEN JULIAOfficer | Grant | 2.3k | — | — | Jun 2, 2026 |
| KOHLER KENNETH EOfficer | Grant | 2.2k | — | — | Jun 2, 2026 |
| MCGOWAN LINDSEYOfficer | Grant | 1.2k | — | — | Jun 2, 2026 |
| ZANGERLE JOHN ADAMGeneral Counsel | Grant | 4.4k | — | — | Jun 2, 2026 |
| BREEDEN RICHARD C.Director | Exercise | 3.8k | $71.40 | $270k | Jun 2, 2026 |
| BREEDEN RICHARD C.Director | Sell | 1.5k | $209.51 | $310k | Jun 2, 2026 |
| FELDMANN CYNTHIA LDirector | Exercise | 3.1k | $152.32 | $472k | Mar 5, 2026 |
| FELDMANN CYNTHIA LDirector | Sell | 3.1k | $237.21 | $735k | Mar 5, 2026 |
| MCGOWAN LINDSEYOfficer | Grant | 798 | — | — | Jan 2, 2026 |
| MADSEN JULIAOfficer | Exercise | 5.0k | $114.22 | $642k | Nov 21, 2025 |
No analyst notes on STE yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 4 | 3 | 0 | 0 | Buy2.11 |
| 1 mo ago | 3 | 4 | 2 | 0 | 0 | Buy1.89 |
| 2 mo ago | 3 | 3 | 2 | 0 | 0 | Buy1.88 |